vs
Side-by-side financial comparison of Natera, Inc. (NTRA) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
SCANSOURCE, INC. is the larger business by last-quarter revenue ($766.5M vs $665.5M, roughly 1.2× Natera, Inc.). Natera, Inc. runs the higher net margin — 7.1% vs 2.2%, a 4.9% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 2.5%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $28.9M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 0.9%).
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
NTRA vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $665.5M | $766.5M |
| Net Profit | $47.3M | $16.5M |
| Gross Margin | — | 13.4% |
| Operating Margin | -3.4% | 2.3% |
| Net Margin | 7.1% | 2.2% |
| Revenue YoY | 39.8% | 2.5% |
| Net Profit YoY | 187.9% | -3.3% |
| EPS (diluted) | $0.36 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $665.5M | $766.5M | ||
| Q3 25 | $592.2M | $739.6M | ||
| Q2 25 | $546.6M | $812.9M | ||
| Q1 25 | $501.8M | $704.8M | ||
| Q4 24 | $476.1M | $747.5M | ||
| Q3 24 | $439.8M | $775.6M | ||
| Q2 24 | $413.4M | $746.1M | ||
| Q1 24 | $367.7M | $752.6M |
| Q4 25 | $47.3M | $16.5M | ||
| Q3 25 | $-87.5M | $19.9M | ||
| Q2 25 | $-100.9M | $20.1M | ||
| Q1 25 | $-66.9M | $17.4M | ||
| Q4 24 | $-53.8M | $17.1M | ||
| Q3 24 | $-31.6M | $17.0M | ||
| Q2 24 | $-37.5M | $16.1M | ||
| Q1 24 | $-67.6M | $12.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | -3.4% | 2.3% | ||
| Q3 25 | -16.5% | 3.5% | ||
| Q2 25 | -20.2% | 3.3% | ||
| Q1 25 | -15.8% | 3.2% | ||
| Q4 24 | -13.6% | 2.5% | ||
| Q3 24 | -8.9% | 2.3% | ||
| Q2 24 | -10.6% | 2.9% | ||
| Q1 24 | -20.2% | 2.3% |
| Q4 25 | 7.1% | 2.2% | ||
| Q3 25 | -14.8% | 2.7% | ||
| Q2 25 | -18.5% | 2.5% | ||
| Q1 25 | -13.3% | 2.5% | ||
| Q4 24 | -11.3% | 2.3% | ||
| Q3 24 | -7.2% | 2.2% | ||
| Q2 24 | -9.1% | 2.2% | ||
| Q1 24 | -18.4% | 1.7% |
| Q4 25 | $0.36 | $0.75 | ||
| Q3 25 | $-0.64 | $0.89 | ||
| Q2 25 | $-0.74 | $0.87 | ||
| Q1 25 | $-0.50 | $0.74 | ||
| Q4 24 | $-0.41 | $0.70 | ||
| Q3 24 | $-0.26 | $0.69 | ||
| Q2 24 | $-0.30 | $0.66 | ||
| Q1 24 | $-0.56 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $83.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $910.9M |
| Total Assets | $2.4B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $83.5M | ||
| Q3 25 | $1.0M | $124.9M | ||
| Q2 25 | $16.0M | $126.2M | ||
| Q1 25 | $17.8M | $146.3M | ||
| Q4 24 | $22.7M | $110.5M | ||
| Q3 24 | $29.5M | $145.0M | ||
| Q2 24 | $90.3M | $185.5M | ||
| Q1 24 | $69.1M | $159.1M |
| Q4 25 | $1.7B | $910.9M | ||
| Q3 25 | $1.3B | $914.0M | ||
| Q2 25 | $1.2B | $906.4M | ||
| Q1 25 | $1.2B | $901.7M | ||
| Q4 24 | $1.2B | $900.7M | ||
| Q3 24 | $878.5M | $920.9M | ||
| Q2 24 | $836.5M | $924.3M | ||
| Q1 24 | $794.1M | $944.1M |
| Q4 25 | $2.4B | $1.7B | ||
| Q3 25 | $1.8B | $1.7B | ||
| Q2 25 | $1.8B | $1.8B | ||
| Q1 25 | $1.7B | $1.7B | ||
| Q4 24 | $1.7B | $1.7B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.5B | $1.8B | ||
| Q1 24 | $1.5B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.9M | $30.8M |
| Free Cash FlowOCF − Capex | $37.8M | $28.9M |
| FCF MarginFCF / Revenue | 5.7% | 3.8% |
| Capex IntensityCapex / Revenue | 5.4% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.56× | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | $109.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.9M | $30.8M | ||
| Q3 25 | $59.4M | $23.2M | ||
| Q2 25 | $37.6M | — | ||
| Q1 25 | $44.5M | $66.1M | ||
| Q4 24 | $52.9M | $-6.2M | ||
| Q3 24 | $51.8M | $44.8M | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $27.0M | $160.2M |
| Q4 25 | $37.8M | $28.9M | ||
| Q3 25 | $37.0M | $20.8M | ||
| Q2 25 | $11.7M | — | ||
| Q1 25 | $22.6M | $64.6M | ||
| Q4 24 | $34.8M | $-8.2M | ||
| Q3 24 | $35.5M | $42.5M | ||
| Q2 24 | $-7.7M | — | ||
| Q1 24 | $6.7M | $157.7M |
| Q4 25 | 5.7% | 3.8% | ||
| Q3 25 | 6.2% | 2.8% | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 4.5% | 9.2% | ||
| Q4 24 | 7.3% | -1.1% | ||
| Q3 24 | 8.1% | 5.5% | ||
| Q2 24 | -1.9% | — | ||
| Q1 24 | 1.8% | 21.0% |
| Q4 25 | 5.4% | 0.3% | ||
| Q3 25 | 3.8% | 0.3% | ||
| Q2 25 | 4.7% | 0.3% | ||
| Q1 25 | 4.3% | 0.2% | ||
| Q4 24 | 3.8% | 0.3% | ||
| Q3 24 | 3.7% | 0.3% | ||
| Q2 24 | 2.8% | 0.2% | ||
| Q1 24 | 5.5% | 0.3% |
| Q4 25 | 1.56× | 1.87× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.79× | ||
| Q4 24 | — | -0.36× | ||
| Q3 24 | — | 2.64× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTRA
Segment breakdown not available.
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
